ClearPoint Neuro Inc.
看多

Clearpoint Neuro

130
Clearpoint Neuro, functional neurosurgery platform with rapid growth within the biologics & gen therapy segment. Breakout out of a multi-year trend with re-test of previous resistance level on low volume. Expecting this to pop over the the next few months with the continued net growth and EPS.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。